Titan Biotech Limited (TITANBIO.BO)
INR 456.8
(-0.87%)
INR 456.8
(-0.87%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 248.53 Million INR | 0.04% |
| 2022 | 248.44 Million INR | 14.57% |
| 2021 | 216.84 Million INR | -28.52% |
| 2020 | 303.35 Million INR | 329.33% |
| 2019 | 70.65 Million INR | 100.6% |
| 2018 | 35.22 Million INR | 38.51% |
| 2017 | 25.42 Million INR | 16.61% |
| 2016 | 21.8 Million INR | 23.34% |
| 2015 | 17.68 Million INR | 8.35% |
| 2014 | 16.31 Million INR | 9.39% |
| 2013 | 14.91 Million INR | 13.74% |
| 2012 | 13.11 Million INR | 5.61% |
| 2011 | 12.41 Million INR | 21.57% |
| 2010 | 10.21 Million INR | 22.73% |
| 2009 | 8.32 Million INR | 17.88% |
| 2008 | 7.06 Million INR | -5.76% |
| 2007 | 7.49 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 63.99 Million INR | 28.09% |
| 2023 Q2 | 65.21 Million INR | 5.86% |
| 2023 Q1 | 61.6 Million INR | 24.43% |
| 2023 Q4 | 49.96 Million INR | -30.36% |
| 2023 FY | 248.53 Million INR | 0.04% |
| 2023 Q3 | 71.74 Million INR | 10.02% |
| 2022 Q3 | 32.61 Million INR | -64.26% |
| 2022 Q4 | 49.51 Million INR | 51.8% |
| 2022 FY | 248.44 Million INR | 14.57% |
| 2022 Q1 | 75.04 Million INR | 50.48% |
| 2022 Q2 | 91.26 Million INR | 21.62% |
| 2021 Q1 | 87.23 Million INR | 131.93% |
| 2021 FY | 216.84 Million INR | -28.52% |
| 2021 Q2 | 63.92 Million INR | -26.72% |
| 2021 Q3 | 52.3 Million INR | -18.17% |
| 2021 Q4 | 49.87 Million INR | -4.66% |
| 2020 FY | 303.35 Million INR | 329.33% |
| 2020 Q2 | 72.09 Million INR | -43.4% |
| 2020 Q3 | 66.24 Million INR | -8.12% |
| 2020 Q4 | 37.61 Million INR | -43.23% |
| 2020 Q1 | 127.39 Million INR | 561.9% |
| 2019 FY | 70.65 Million INR | 100.6% |
| 2019 Q1 | 19.56 Million INR | 568.5% |
| 2019 Q2 | 14.24 Million INR | -27.17% |
| 2019 Q3 | 17.6 Million INR | 23.58% |
| 2019 Q4 | 19.24 Million INR | 9.33% |
| 2018 Q3 | 9.1 Million INR | -16.46% |
| 2018 Q4 | 2.92 Million INR | -67.86% |
| 2018 Q2 | 10.89 Million INR | 26.21% |
| 2018 Q1 | 8.63 Million INR | -34.7% |
| 2018 FY | 35.22 Million INR | 38.51% |
| 2017 Q3 | 7.78 Million INR | 95.58% |
| 2017 FY | 25.42 Million INR | 16.61% |
| 2017 Q4 | 13.22 Million INR | 69.77% |
| 2017 Q2 | 3.98 Million INR | -34.55% |
| 2017 Q1 | 6.08 Million INR | -30.92% |
| 2016 Q4 | 8.8 Million INR | 207.08% |
| 2016 FY | 21.8 Million INR | 23.34% |
| 2016 Q1 | 4.58 Million INR | -15.32% |
| 2016 Q3 | 2.86 Million INR | -48.35% |
| 2016 Q2 | 5.55 Million INR | 21.19% |
| 2015 FY | 17.68 Million INR | 8.35% |
| 2015 Q4 | 5.41 Million INR | 26.77% |
| 2015 Q3 | 4.26 Million INR | -6.85% |
| 2015 Q2 | 4.58 Million INR | 19.6% |
| 2015 Q1 | 3.83 Million INR | -7.74% |
| 2014 Q1 | 3.68 Million INR | 3.81% |
| 2014 FY | 16.31 Million INR | 9.39% |
| 2014 Q3 | 4.05 Million INR | -8.72% |
| 2014 Q2 | 4.43 Million INR | 20.57% |
| 2014 Q4 | 4.15 Million INR | 2.53% |
| 2013 Q2 | 4.07 Million INR | 19.45% |
| 2013 Q4 | 3.54 Million INR | -8.66% |
| 2013 Q1 | 3.41 Million INR | 6.51% |
| 2013 Q3 | 3.88 Million INR | -4.83% |
| 2013 FY | 14.91 Million INR | 13.74% |
| 2012 Q4 | 3.2 Million INR | 24.82% |
| 2012 Q1 | 3.4 Million INR | -5.76% |
| 2012 Q2 | 3.77 Million INR | 10.93% |
| 2012 Q3 | 2.56 Million INR | -31.97% |
| 2012 FY | 13.11 Million INR | 5.61% |
| 2011 Q4 | 3.61 Million INR | 29.71% |
| 2011 Q3 | 2.78 Million INR | 0.0% |
| 2011 FY | 12.41 Million INR | 21.57% |
| 2010 Q4 | 1.64 Million INR | 0.0% |
| 2010 FY | 10.21 Million INR | 22.73% |
| 2009 FY | 8.32 Million INR | 17.88% |
| 2008 FY | 7.06 Million INR | -5.76% |
| 2008 Q4 | 278 Thousand INR | 0.0% |
| 2007 FY | 7.49 Million INR | 0.0% |
| 2007 Q4 | 1.59 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 2.76 Million INR | -8891.679% |
| Biocon Limited | 10.22 Billion INR | 97.569% |
| Blue Jet Healthcare Limited | 1.63 Billion INR | 84.823% |
| Concord Biotech Limited | 3.08 Billion INR | 91.934% |
| Dishman Carbogen Amcis Limited | -1.53 Billion INR | 116.196% |
| FERMENTA BIOTECH LIMITED | -230.59 Million INR | 207.776% |
| GENOMIC VALLEY BIOTECH LIMITED | 151.81 Thousand INR | -163602.591% |
| Lyka Labs Limited | -24.89 Million INR | 1098.353% |
| Panacea Biotec Limited | -11.73 Million INR | 2218.755% |
| SAMSRITA LABS LIMITED | -2.62 Million INR | 9577.016% |
| Servoteach Industries Limited | -2.37 Million INR | 10568.829% |
| SMS Lifesciences India Limited | 90.92 Million INR | -173.326% |
| Supriya Lifescience Limited | 1.19 Billion INR | 79.135% |
| Syngene International Limited | 5.1 Billion INR | 95.127% |
| TAKE Solutions Limited | -1.19 Billion INR | 120.777% |
| Transgene Biotek Limited | -6.55 Million INR | 3891.457% |
| Vanta Bioscience Limited | -23.15 Million INR | 1173.147% |